BRIEF-TAG Oil Signs Definitive Agreement To Sell Its New Zealand Royalty Interests-May 2024-www.financetom.com

BRIEF-TAG Oil Signs Definitive Agreement To Sell Its New Zealand Royalty Interests

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-TAG Oil Signs Definitive Agreement To Sell Its New Zealand Royalty Interests

Apr 8, 2025 7:03 AM

April 8 (Reuters) - TAG Oil Ltd ( TAOIF ):

* TAG OIL SIGNS DEFINITIVE AGREEMENT TO SELL ITS NEW ZEALAND

ROYALTY INTERESTS

* TAG OIL LTD ( TAOIF ) - TO RECEIVE UP TO $2.5 MILLION FROM SALE

Source text:

Further company coverage:

Previous page： Walgreens settles New York charges it inflated prices of infant formula Next page： BRIEF-Assure Holdings Enters Into Agreement To Sell Certain Of Its Assets To MPOWERHealth

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Walgreens settles New York charges it inflated prices of infant formula

Mar 11, 2024

NEW YORK (Reuters) - Walgreens has settled charges by New York Attorney General Letitia James that the pharmacy chain grossly inflated prices on at least 20 infant formula products in 2022 after a recall by Abbott Labs led to a nationwide shortage. Walgreens did not admit or deny wrongdoing in entering an assurance of discontinuance dated March 7 and made...

BRIEF-Assure Holdings Enters Into Agreement To Sell Certain Of Its Assets To MPOWERHealth

Mar 11, 2024

March 11 (Reuters) - Assure Holdings Corp ( IONM ): * ASSURE HOLDINGS ENTERS INTO AGREEMENT TO SELL CERTAIN OF ITS ASSETS TO MPOWERHEALTH * ASSURE HOLDINGS CORP ( IONM ): TO SELL CERTAIN ASSETS OF ITS IONM BUSINESS TO MPOWERHEALTH FOR UP TO $4.5 MILLION Source text for Eikon: Further company coverage: ...

Acadia to stop trials of antipsychotic drug after it fails schizophrenia study

Mar 11, 2024

March 11 (Reuters) - Acadia Pharmaceuticals ( ACAD ) said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative symptoms of schizophrenia in a late-stage study. Shares of the California-based company fell 16% in extended trading. The decision comes after two failed attempts to secure regulatory approval...

Atlassian Insider Sold Shares Worth $1,717,897, According to a Recent SEC Filing

Mar 11, 2024

05:26 PM EDT, 03/11/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on March 08, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,717,897. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 115,374 shares of the company, with 115,374 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024002541/xslF345X03/primarydocument.xml Price: 215.82, Change: +0.19, Percent...